Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorHernando Cubero, Jorge
dc.contributor.authorAlonso, Lola
dc.contributor.authorFasani, Roberta
dc.contributor.authorJiménez Flores, José Antonio
dc.contributor.authorElez Fernandez, Mª Elena
dc.contributor.authorTabernero Caturla, Josep
dc.contributor.authorNuciforo, Paolo Giovanni
dc.contributor.authorCapdevila Castillon, Jaume
dc.contributor.authorLandolfi, Stefania
dc.contributor.authorComas Navarro, Raquel
dc.contributor.authorRuiz Pace, Fiorella
dc.contributor.authorSerna, Garazi
dc.contributor.authorDienstmann, Rodrigo
dc.date.accessioned2021-10-04T12:58:49Z
dc.date.available2021-10-04T12:58:49Z
dc.date.issued2020-10
dc.identifier.citationSerna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, et al. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol. 2020 Oct;31(10):1366–75.
dc.identifier.issn0923-7534
dc.identifier.urihttps://hdl.handle.net/11351/6378
dc.descriptionFusobacterium nucleatum; Càncer de recte avançat local; Quimioteràpia preoperatòria
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesAnnals of Oncology;31(10)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectBacteris gramnegatius
dc.subjectRecte - Càncer - Quimioteràpia
dc.subjectRecte - Càncer - Radioteràpia
dc.subject.meshRectal Neoplasms
dc.subject.meshFusobacterium nucleatum
dc.subject.meshChemoradiotherapy
dc.titleFusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.annonc.2020.06.003
dc.subject.decsneoplasias del recto
dc.subject.decsFusobacterium nucleatum
dc.subject.decsquimiorradioterapia
dc.relation.publishversionhttps://doi.org/10.1016/j.annonc.2020.06.003
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Serna G, Alonso L, Fasani R, Jimenez J, Nuciforo P] Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz-Pace F, Comas R, Dienstmann R] Oncology Data Science Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hernando J, Elez E, Capdevila J] Servei d’Oncologia Mèdica, Unitat de Tumors gastrointestinals i endocrins, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Landolfi S] Servei d’Anatomia Patològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain
dc.identifier.pmid32569727
dc.identifier.wos000574680100001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple